Incidence of therapy-related myeloid neoplasia after initial therapy for chronic lymphocytic leukemia with fludarabine-cyclophosphamide versus fludarabine: long-term follow-up of US Intergroup Study E2997

समान संसाधन

• Cytogenetic Prioritization with Inclusion of Molecular Markers Predicts Outcome in Previously Untreated Chronic Lymphocytic Leukemia Patients Treated with Fludarabine or Fludarabine Plus Cyclophosphamide: A Long-Term Follow-Up Study of the U.S. Intergroup Phase III Trial E2997
  द्वारा: Lucas, David M., और अन्य
  प्रकाशित: (2015)
• The Impact of Initial Fludarabine Therapy on Transformation to Richter’s Syndrome or Prolymphocytic Leukemia in Patients with Chronic Lymphocytic Leukemia: Analysis of an Intergroup Trial (CALGB 9011)
  द्वारा: Solh, Melhem, और अन्य
  प्रकाशित: (2012)
• Comparison of pediatric allogeneic transplant outcomes using myeloablative busulfan with cyclophosphamide or fludarabine
  द्वारा: Harris, Andrew C., और अन्य
  प्रकाशित: (2018)
• Fludarabine, Cyclophosphamide, and Multiple-Dose Rituximab as Frontline Therapy for Chronic Lymphocytic Leukemia
  द्वारा: Short, Nicholas J., और अन्य
  प्रकाशित: (2015)
• Obinutuzumab plus fludarabine/cyclophosphamide or bendamustine in the initial therapy of CLL patients: the phase 1b GALTON trial
  द्वारा: Brown, Jennifer R., और अन्य
  प्रकाशित: (2015)